Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment
The inconsistent inclusion of family spillover effects in HTAs and CEAs remains a persistent challenge. The stakeholder-driven recommendations and research opportunities identified in this study may help improve the transparency, measurement, and use of family spillover effects in assessing the clinical and economic value of novel medical technologies.
Authors
- Josh John Carlson (ORCID: https://orcid.org/0000-0001-7664-8370)
- Stacey Kowal (ORCID: https://orcid.org/0000-0001-6018-6052)
- Rajshree Pandey (ORCID: https://orcid.org/0000-0001-7682-1049)
- David L. Veenstra (ORCID: https://orcid.org/0000-0003-0687-0480)
- Christopher J. Wallick (ORCID: https://orcid.org/0000-0003-2521-5895)
- David J. Campbell
- Lisa Bloudek
Institutions
- University of Washington (US)
- Behavioral Tech Research, Inc. (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2024-08-30
- DOI
- https://doi.org/10.18553/jmcp.2024.30.9.1013
- Citations
- 5
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 5.65